Relay Therapeutics (RLAY) Return on Sales (2020 - 2025)
Historic Return on Sales for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to 35.52%.
- Relay Therapeutics' Return on Sales fell 10200.0% to 35.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 35.52%, marking a year-over-year decrease of 10200.0%. This contributed to the annual value of 33.75% for FY2024, which is 203600.0% down from last year.
- As of Q3 2025, Relay Therapeutics' Return on Sales stood at 35.52%, which was down 10200.0% from 103.02% recorded in Q2 2025.
- Relay Therapeutics' 5-year Return on Sales high stood at 83496.0% for Q4 2023, and its period low was 827.66% during Q2 2023.
- For the 5-year period, Relay Therapeutics' Return on Sales averaged around 4245.31%, with its median value being 91.34% (2021).
- Per our database at Business Quant, Relay Therapeutics' Return on Sales soared by 837627200bps in 2023 and then crashed by -835297500bps in 2024.
- Quarter analysis of 5 years shows Relay Therapeutics' Return on Sales stood at 118.97% in 2021, then tumbled by -124bps to 266.72% in 2022, then soared by 31405bps to 83496.0% in 2023, then plummeted by -100bps to 33.75% in 2024, then dropped by -5bps to 35.52% in 2025.
- Its last three reported values are 35.52% in Q3 2025, 103.02% for Q2 2025, and 10.03% during Q1 2025.